Related Experiment Videos
Fixed-dose combinations as initial therapy for hypertension: a review of approved agents and a guide to patient
Bernard Waeber1, François Feihl, Luis M Ruilope
1Division of Clinical Pathophysiology, Centre Hospitalier Universitaire Vaudois et Université de Lausanne, MP 14/204 Lausanne, CH-1011, Switzerland. Bernard.Waeber@chuv.ch
Abstract:
Recent guidelines recommend initiation of antihypertensive therapy with fixed-dose combinations in high-risk patients because such patients usually need two or more blood pressure (BP)-lowering agents in order to normalize their BP. Agents that block the renin-angiotensin system (ACE inhibitors or angiotensin II receptor antagonists [angiotensin receptor blockers; ARBs]) are preferred for the management of hypertension in most patients exhibiting subclinical target organ damage, or established cardiovascular or renal diseases. Unless contraindicated they should be one of the components of fixed-dose combinations, whereas the other component may be either a calcium channel antagonist or a thiazide diuretic. Fixed-dose combinations containing an ACE inhibitor or ARB plus a calcium channel antagonist appear particularly effective in preventing complications of coronary heart disease.
Related Concept Videos
Hypertension IV: Drug Therapy and Lifestyle Modifications
Heart Failure V: Medical Management
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Dosage Regimen Designs: Nomograms and Tabulations
Antihypertensive Drugs: Direct Renin Inhibitors